Volume 43, Issue 1, Pages (January 2003)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Managing Cancer Pain: Basic Principles and Invasive Treatments
Volume 70, Issue 1, Pages (July 2016)
Testosterone Therapy in Men With Prostate Cancer
Volume 63, Issue 5, Pages (May 2013)
Volume 61, Issue 5, Pages (May 2012)
Volume 66, Issue 6, Pages (December 2014)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Prostate Cancer Epidemic in Sight?
Volume 45, Issue 4, Pages (April 2004)
Volume 63, Issue 1, Pages (January 2013)
Bladder Cancer: A Major Public Health Issue
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
What is New in Bladder Cancer Diagnosis and Management?
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Back to the Future: Introduction and Conclusions
Volume 61, Issue 4, Pages (April 2012)
Prostate Cancer Detection: A View of the Future
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Volume 63, Issue 5, Pages (May 2013)
Volume 69, Issue 3, Pages (March 2016)
Volume 70, Issue 1, Pages (July 2016)
Volume 64, Issue 3, Pages (September 2013)
Counselling the Prostate Cancer Patient
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
The PSA Era is not Over for Prostate Cancer
Global Burden of Urologic Cancers, 1990–2013
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
The Economic Costs of Overactive Bladder in Germany
Volume 50, Issue 5, Pages (November 2006)
Volume 50, Issue 3, Pages (September 2006)
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Volume 52, Issue 6, Pages (December 2007)
Adrenal Tumours European Urology
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Testicular Cancer Variations in Time and Space in Europe
Oral versus intravenous therapy in the treatment of systemic mycosis
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008  C.-K. Tan, C.-C.
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
Acute schistosomiasis, a diagnostic and therapeutic challenge
European Urology is “Your” Journal
New Trends in Managing the Prostate Cancer Patient
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Antibacterial drug discovery in the 21st century
Current experience in treating invasive zygomycosis with posaconazole
Economic Burden of Bladder Cancer Across the European Union
Listeriosis: a resurgent foodborne infection
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
The atypical pneumonias: clinical diagnosis and importance
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Joaquim Bellmunt  European Urology Supplements 
B.A. Cunha  Clinical Microbiology and Infection 
Cancer therapy: Less blood means more sanguinity
Epidemiology and Demographics of Prostatitis
Jan Roigas  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Managing Cancer Pain: Basic Principles and Invasive Treatments
Volume 51, Issue 5, Pages (May 2007)
News & Notes Journal of Allergy and Clinical Immunology
The future of diagnostic bacteriology
Presentation transcript:

Volume 43, Issue 1, Pages 53-62 (January 2003) Gender-Related Differences in Clinical and Pathological Characteristics and Therapy of Bladder Cancer  D Puente, N Malats, L Cecchini, A Tardón, R Garcı́a-Closas, C Serra, A Carrato, M Sala, R Boixeda, M Dosemeci, F.X Real, M Kogevinas  European Urology  Volume 43, Issue 1, Pages 53-62 (January 2003) DOI: 10.1016/S0302-2838(02)00496-7

Fig. 1 Diagnostic tests applied according to gender and invasiveness. European Urology 2003 43, 53-62DOI: (10.1016/S0302-2838(02)00496-7)

Fig. 2 Differences between genders on the number of tumours and size of the largest mass according to diagnostic test used. European Urology 2003 43, 53-62DOI: (10.1016/S0302-2838(02)00496-7)